2,2-bis(bromomethyl)-1,3-propanediol has been researched along with Metabolic Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| AURICCHIO, S; MUERSET, G; PRADER, A | 1 |
| DUGAS, M; GOURGON, R; GRENET, P; INIGUEZ, M; LESTRADET, H | 1 |
2 other study(ies) available for 2,2-bis(bromomethyl)-1,3-propanediol and Metabolic Diseases
| Article | Year |
|---|---|
[Diarrhea due to hereditary deficiency of intestinal saccharase activity (saccharose intolerance)].
Topics: beta-Fructofuranosidase; Child; Diarrhea; Glycoside Hydrolases; Infant; Intestines; Metabolic Diseases; Sucrose | 1961 |
[Absence of saccharase, a cause of chronic diarrhea in an infant].
Topics: beta-Fructofuranosidase; Diarrhea; Diarrhea, Infantile; Glycoside Hydrolases; Humans; Infant; Metabolic Diseases | 1962 |